1. Market Research
  2. > Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later

The Lifting of Nuclear Sanctions on Iran will open a Plethora of Opportunities in the Medical Tourism and Pharmaceutical Sectors

Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacity. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $415.3 billion in 2014. The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial transactions, severely affecting the pharmaceutical and medical tourism sectors. This report assesses the impact of the lifting of these international sanctions on Iran’s healthcare market. It analyses market dynamics such as drivers and restraints and also provides estimates on the future of Iran’s pharmaceutical and medical tourism sectors.

Iran’s Healthcare Market—Growth Potential
- Several international sanctions were imposed over Iran over the last decade, restraining its international trade capacities. Yet, Iran is the 17th largest economy in the world; its Gross Domestic Product (GDP) was $ billion in 2014.
- The nuclear sanctions imposed by the United Nations on Iran resulted in trade bans and restrictions on financial transactions, severely affecting the pharmaceutical and medical tourism sectors.
- Despite the import of food and drugs being exempted from sanctions, there has been a shortage of imported drugs due to financial road blocks such as restrictions on SWIFT payment methods.
- From 2015 onwards, there is an increasing international consensus to ease nuclear sanctions. This will likely allow the Iranian pharmaceutical sector to produce adequate drugs needed for domestic use. This
will also improve the prospect of Iran opening up to trade and providing opportunities for pharmaceutical companies to be a part of its growth. Frost & Sullivan expects that by mid-2016, there will be a positive
momentum to support lifting of sanctions over Iran, especially by the US Congress while the International Atomic Energy Agency (IAEA) verifies Iran’s compliance with nuclear deal requirements.
- Frost & Sullivan expects that this ease will increase the import of drugs as well as boost manufacturing from the pharmaceutical companies for generic drugs licensed by European and US companies.
- The government of Iran is more reform-oriented to position Iran as a business friendly nation, and it took effective measures to bring inflation under control at % in the first half of 2015 .
- International companies have gradually started to leverage this positive environment. Novo Nordisk plans to build a manufacturing plant for approximately $ million (€ million) in Iran. Iranian companies
benefit with increased access to finance and technology, while the Iranian people will benefit from a competitive healthcare landscape and improved value for money.

Economic Overview of Iran
Iran’s economy is extremely dependent on its oil and gas sector. The nuclear sanctions imposed by the United Nations in 2010 had an adverse effect on inflation and employment, as inflation rose to % in 2012. Since 2013, it has been decreasing and is at % in 2015.

While Iran faced several sanctions and trade constraints in the last three decades, countries such as China, South Korea, Turkey, Russia, and other Middle Eastern countries have become trade partners of Iran.

Iran, with a population of million, is the 17th most heavily populated country in the world with the 17th largest economy.

Table Of Contents

Impact of Lifting Nuclear Sanctions on Iran’s Healthcare Market—Now and Later
Executive Summary
Iran's Healthcare Market—Growth Potential

Market Overview
Economic Overview of Iran
Iran—Country Snapshot
Iran—Healthcare Overview
Healthcare Expenditure
Healthcare System of Iran
Demographics—Population by Age
Healthcare Indicators
Leading Causes of Deaths in Iran
Timeline of Iran's Healthcare Market

Impact of Nuclear Sanctions on Iran
Nuclear Sanctions and its Implications for Iran
Embargoes on Iran
Fall of Medicinal Imports
Sanctions on Banking Systems
Price Inflation

The Lifting of Sanctions to Transform Iran's Healthcare Market
Lifting Sanctions to Boost Healthcare Market
What are the Market Attractions in Iran?
What Does the Iranian Healthcare Market Offer?

Drivers and Restraints
Market Drivers
Market Restraints

Opportunities in Iran's Healthcare Market After Sanctions are Lifted
Healthcare Market Opportunities in Iran
Medical Tourism—After Sanctions are Lifted
Iran's Medical Tourism Sector—A Growing Medical Hub
Pharmaceuticals—After Sanctions are Lifted
Pharmaceuticals—Market Statistics
Generic Drugs Market in Iran
Competitive Landscape of Generic Drugs
Novo Nordisk to Explore Iran After Sanctions are Lifted
Medical Devices—After Sanctions are Lifted
Medical Devices—Market Statistics

Strategic Recommendations
Future Outlook of Iran's Healthcare Market
3 Key Predictions

The Last Word
Legal Disclaimer

The Frost and Sullivan Story
Value Proposition: Future of Your Company and Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.